The results of the Tokyo Trial of Prevention of Post-ERCP Pancreatitis with Risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial

Author: Tsujino Takeshi   Isayama Hiroyuki   Nakai Yousuke   Ito Yukiko   Togawa Osamu   Toda Nobuo   Arizumi Toshihiko   Kogure Hirofumi   Yamamoto Keisuke   Mizuno Suguru   Yashima Yoko   Yagioka Hiroshi   Sasaki Takashi   Matsubara Saburo   Yamamoto Natsuyo   Hirano Kenji   Sasahira Naoki   Tada Minoru   Koike Kazuhiko  

Publisher: Springer Publishing Company

ISSN: 0944-1174

Source: Journal of Gastroenterology, Vol.48, Iss.8, 2013-08, pp. : 982-988

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content